BioInvent International AB (publ) (LON:0H22)
 33.50
 +3.05 (10.02%)
  At close: Oct 30, 2025
LON:0H22 Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
 Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 | 
|---|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 | 
| Cash & Equivalents | 483.27 | 434.83 | 259.55 | 515.05 | 910.76 | 729.27 | Upgrade  | 
| Short-Term Investments | 207.18 | 432.33 | 809.15 | 502.43 | 172.07 | - | Upgrade  | 
| Cash & Short-Term Investments | 690.46 | 867.16 | 1,069 | 1,017 | 1,083 | 729.27 | Upgrade  | 
| Cash Growth | -27.33% | -18.86% | 5.03% | -6.04% | 48.48% | 373.63% | Upgrade  | 
| Accounts Receivable | 48.96 | 8.27 | 11.93 | 15.78 | 0.37 | 29.92 | Upgrade  | 
| Other Receivables | - | 22.98 | 27.76 | 24.19 | 12.54 | 7.88 | Upgrade  | 
| Receivables | 48.96 | 31.25 | 39.69 | 39.97 | 12.91 | 37.8 | Upgrade  | 
| Inventory | 9.42 | 10.97 | 11.84 | 11.51 | 16.85 | 4.08 | Upgrade  | 
| Prepaid Expenses | - | 33.84 | 13.04 | 15.11 | 3.43 | 1.9 | Upgrade  | 
| Total Current Assets | 748.84 | 943.21 | 1,133 | 1,084 | 1,116 | 773.04 | Upgrade  | 
| Property, Plant & Equipment | 36.98 | 46.02 | 52.66 | 52.01 | 49.08 | 29.6 | Upgrade  | 
| Long-Term Investments | - | - | 214.25 | 576.14 | 282.21 | - | Upgrade  | 
| Total Assets | 785.82 | 989.24 | 1,400 | 1,712 | 1,447 | 802.64 | Upgrade  | 
| Accounts Payable | - | 49.1 | 29.19 | 41.35 | 19.72 | 16.91 | Upgrade  | 
| Accrued Expenses | - | 24.78 | 25.01 | 22.91 | 16.89 | 14.39 | Upgrade  | 
| Current Portion of Leases | 9.09 | 9.2 | 8.71 | 8.19 | 6.84 | 5.97 | Upgrade  | 
| Other Current Liabilities | 92.12 | 12.13 | 13.01 | 14.88 | 15.35 | 16.23 | Upgrade  | 
| Total Current Liabilities | 101.21 | 95.21 | 75.92 | 87.32 | 58.79 | 53.51 | Upgrade  | 
| Long-Term Leases | 1.59 | 8.22 | 14.54 | 18.77 | 21.53 | 5.63 | Upgrade  | 
| Total Liabilities | 102.8 | 103.42 | 90.45 | 106.09 | 80.32 | 59.14 | Upgrade  | 
| Common Stock | 683.02 | 13.16 | 13.16 | 12.99 | 11.69 | 78.75 | Upgrade  | 
| Additional Paid-In Capital | - | 3,759 | 3,759 | 3,728 | 3,450 | 2,482 | Upgrade  | 
| Retained Earnings | - | -2,887 | -2,463 | -2,135 | -2,095 | -1,817 | Upgrade  | 
| Comprehensive Income & Other | - | 0 | 0 | 0 | 0 | 0 | Upgrade  | 
| Shareholders' Equity | 683.02 | 885.82 | 1,310 | 1,606 | 1,367 | 743.5 | Upgrade  | 
| Total Liabilities & Equity | 785.82 | 989.24 | 1,400 | 1,712 | 1,447 | 802.64 | Upgrade  | 
| Total Debt | 10.69 | 17.41 | 23.24 | 26.96 | 28.37 | 11.6 | Upgrade  | 
| Net Cash (Debt) | 679.77 | 849.75 | 1,045 | 990.52 | 1,054 | 717.67 | Upgrade  | 
| Net Cash Growth | -27.15% | -18.72% | 5.55% | -6.06% | 46.93% | 418.37% | Upgrade  | 
| Net Cash Per Share | 10.34 | 12.91 | 15.90 | 16.10 | 19.47 | 24.99 | Upgrade  | 
| Filing Date Shares Outstanding | 65.93 | 65.8 | 65.8 | 65.8 | 58.47 | 58.47 | Upgrade  | 
| Total Common Shares Outstanding | 65.93 | 65.8 | 65.8 | 64.97 | 58.47 | 39.38 | Upgrade  | 
| Working Capital | 647.63 | 848.01 | 1,057 | 996.74 | 1,057 | 719.54 | Upgrade  | 
| Book Value Per Share | 10.36 | 13.46 | 19.90 | 24.72 | 23.38 | 18.88 | Upgrade  | 
| Tangible Book Value | 683.02 | 885.82 | 1,310 | 1,606 | 1,367 | 743.5 | Upgrade  | 
| Tangible Book Value Per Share | 10.36 | 13.46 | 19.90 | 24.72 | 23.38 | 18.88 | Upgrade  | 
| Buildings | - | 16.51 | 16.25 | 16.25 | 15.84 | 15.57 | Upgrade  | 
| Machinery | - | 97.76 | 92.67 | 84.31 | 73.79 | 77.38 | Upgrade  | 
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.